Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 7,789-7,800 of 10,612

Drug study icon

CompletedNCT00825539

Pharmacodynamic/Pharmacokinetic Study of AQW051 in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Novartis Pharmaceuticals
Condition: Schizophrenia

Other study type icon

CompletedNCT02374996

Pharmacoepigenetics of Bipolarity Treatment

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityObservationalFrom 18 Years to 65 Years

Countries: United States
Sponsor: Wayne State University
Condition: Bipolarity

Drug study icon

WithdrawnNCT00641511

Pharmacogenetic study of Nepicastat for PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Michael E. DeBakey VA Medical Center
Condition: PTSD

Other study type icon

CompletedNCT04469322

Pharmacogenetic Implementation study in Veterans With Treatment Refractory Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, BipolarityDiagnostic TestOver 18 Years

Countries: United States
Sponsor: San Diego Veterans Healthcare System
Condition: Depression, Bipolarity

Behavioral study icon

CompletedNCT02354703

Pharmacogenetic Study of Ondansetron in Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 70 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Addiction

Drug study icon

CompletedNCT02884908

Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: PTSD, Addiction

Drug study icon

WithdrawnNCT01591291

Pharmacogenetic Treatments for Alcoholism

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Virginia
Condition: Addiction

Behavioral study icon

CompletedNCT01953432

Pharmacogenetic study of Doxazosin for Treatment of Cocaine Abuse

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Mental healthBehavioralFrom 18 Years to 64 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Mental health

Drug study icon

CompletedNCT00678730

Pharmacogenetics of Cannabinoid Response

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Drug study icon

CompletedNCT03226223

Pharmacogenetics of Naltrexone for Stimulant Abuse

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 50 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Addiction

Drug study icon

CompletedNCT01314001

Pharmacogenetics of Nicotine Addiction Treatment

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States, Canada
Sponsor: University of Pennsylvania
Condition: Addiction

Drug study icon

CompletedNCT00507728

Pharmacogenetics, Emotional Reactivity and Smoking

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: M.D. Anderson Cancer Center
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.